Brentuximab vedotin with chemotherapy in adolescents and young adults (AYA) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 ECHELON-1 study Meeting Abstract
| Authors: | Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Fenton, K.; Engley, G.; Jolin, H.; Liu, R.; Zinzani, P. L.; Collins, G. P.; Grigg, A. P. |
| Abstract Title: | Brentuximab vedotin with chemotherapy in adolescents and young adults (AYA) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 ECHELON-1 study |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837605024 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-112907 |
| Notes: | Meeting Abstract: 1647 -- Source: Wos |
